Analyst Ratings for Edwards Lifesciences (EW)
EW Rating Summary
EW Price Target Summary
- Highest: $110.00 (Barclays)
- Lowest: $85.00 (Canaccord)
- Average: $100.13
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$100.13 (+15.6%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
Avg. $ Target:
$100.13 (+15.6%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/6/2026 | Barclays | Matt Miksic | New Coverage | Overweight (N/A) |
110.00 (N/A) |
87.23 (86.60) |
-0.72% | Details |
| 7/28/2026 | UBS » Updated 10/8/2026 |
Patrick Wood | New Coverage | Buy (N/A) |
110.00 (110.00) |
83.04 (86.60) |
4.29% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
